Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Banting Postdoctoral Fellowship Program

Université de Montréal

$140,000.00

The role of 14-3-3zeta-mediated RNA splicing during the development of obesity

EF 2018-19

Résumé
Obesity is a well-known risk factor for chronic diseases, including type 2 diabetes and heart disease. Despite intensive research, there are no treatments that effectively promote weight loss for long periods of time. At the center of obesity is the fat cell. Surprisingly, no treatments specifically target fat cells, which need a complicated roadmap of signals to grow. One protein that provides direction for these signals is 14-3-3zeta, which we previously found to have important roles in the growth of fat cells. Depending on conditions, proteins that interact with 14-3-3zeta can change. For example, during fat cell growth, a large number of proteins that interact with 14-3-3zeta are those that influence RNA splicing. When RNA splicing is inhibited, fat cells do not develop properly. Recently, high-fat diet-induced obesity has been found to alter RNA splicing in fat cells. This raises the question of whether obesity causes the aberrant recruitment of 14-3-3zeta-associated RNA splicing factors, thereby promoting the development of obesity. Therefore, in my post-doctoral fellowship, I wish to undertake new studies aimed at testing whether altered RNA splicing promotes the development of obesity and understand in great detail how 14-3-3zeta controls this process in a fat cell. Results from these studies will determine whether 14-3-3zeta can influence the development of obesity, and they may lead to new ways to prevent or treat obesity, a disease that affects people of all ages and throughout the world.
Programme
Banting Postdoctoral Fellowship Program
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
392429
Name
Mugabo Yves
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
The role of 14-3-3zeta-mediated RNA splicing during the development of obesity
Programtype2
Fellowship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
14-3-3; Adipocytes; Adipogenesis; Interactome; Knockout Mice; Obesity; Obesogenic Factors; Proteomics; Rna Splicing; Transcriptomics
Abstract
Obesity is a well-known risk factor for chronic diseases, including type 2 diabetes and heart disease. Despite intensive research, there are no treatments that effectively promote weight loss for long periods of time. At the center of obesity is the fat cell. Surprisingly, no treatments specifically target fat cells, which need a complicated roadmap of signals to grow. One protein that provides direction for these signals is 14-3-3zeta, which we previously found to have important roles in the growth of fat cells. Depending on conditions, proteins that interact with 14-3-3zeta can change. For example, during fat cell growth, a large number of proteins that interact with 14-3-3zeta are those that influence RNA splicing. When RNA splicing is inhibited, fat cells do not develop properly. Recently, high-fat diet-induced obesity has been found to alter RNA splicing in fat cells. This raises the question of whether obesity causes the aberrant recruitment of 14-3-3zeta-associated RNA splicing factors, thereby promoting the development of obesity. Therefore, in my post-doctoral fellowship, I wish to undertake new studies aimed at testing whether altered RNA splicing promotes the development of obesity and understand in great detail how 14-3-3zeta controls this process in a fat cell. Results from these studies will determine whether 14-3-3zeta can influence the development of obesity, and they may lead to new ways to prevent or treat obesity, a disease that affects people of all ages and throughout the world.
Competitiondate
201809
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Mugabo, Yves
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~